Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
New This Tax Season: H&R Block Filers Could Receive Up To $4,000 With Refund Advance Loan
-
Beyond Air to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
-
Elutia Announces EluPro™ GPO Agreement with Southern Strategic Sourcing Partners
-
LGI Homes Unveils New Jacksonville-Area Community: Jennings Farm
-
NV5 Authorizes $20 Million Share Repurchase
-
Steakholder Foods to Present at the 27th Annual ICR Conference
-
Patient Enrolment Completed for INSIGHT-003
-
PharmaTher CEO Issues Letter to Shareholders
-
BitFuFu Announces December 2024 Production and Mining Operations Update
-
Perspective Therapeutics Appoints Juan Graham, MBA as Chief Financial Officer
-
Crinetics Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
-
RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company’s Board of Directors
-
Tempest Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma (HCC)
-
Compass Diversified Declares Fourth Quarter 2024 Distributions on Common and Series A, B and C Preferred Shares
-
Duos Closes Asset Management Deal with Fortress Investment Group
-
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Prestige Consumer Healthcare Inc. Expands CFO Christine Sacco’s Role to Include Chief Operating Officer Responsibilities
-
Microbot Medical Announces $7 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
-
Cellebrite Appoints Michael D. Capellas to Board of Directors as Lead Independent Director
-
CERo Therapeutics Holdings, Inc. Announces Reverse Stock Split
-
Rezolve Ai to Exhibit at NRF 2025: Retail’s Big Show in New York City
-
CareCloud Announces 94% Shareholder Support for Proposal to Increase Authorized Shares
-
ARS Pharmaceuticals Files for Approval of neffy® in Canada and the United Kingdom on Behalf of Licensing Partner ALK-Abelló A/S
-
Healthy Choice Wellness Corp. Announces Record Fourth Quarter and Year-End 2024 Sales and Gross Margin Performance
-
Kratos Receives $1.45B MACH-TB 2.0 Contract Award
-
D. Boral Capital Served as Underwriter to Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) in connection with its $4.8 Million Initial Public Offering
-
Brera Holdings Board Member Goran Pandev Appointed Sports Director of North Macedonia's National Teams
-
Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health
-
Myriad Genetics Issues Quality, Innovation, and Corporate Responsibility Report
-
Ardelyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Charles Cynamon Named President of Telesat Government Solutions
-
Abercrombie & Fitch Co. to Present at the 2025 ICR Conference
-
Stryker to announce financial results for its fourth quarter and full year 2024
-
Sagimet Biosciences Announces Oral Presentation at the 9th Annual MASH-TAG 2025 Conference
-
Sparton Provides Updated Information on the VRB Energy-Lubao Group Joint Venture Activities
-
Wearable Devices Announces General Availability of its Mudra Link Neural Gesture-Control Wristband
-
Eyenuk Appoints Mads Dall as Chairman of the Board and Gaurav Agarwal as Chief Executive Officer
-
Lexitas Elevates Nishat Mehta to CEO, Prepares to Launch AI-Assisted Solutions for the Legal Profession Throughout 2025
-
SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment
-
Form 8.3 - Learning Technologies Group plc - Octopus Investments
-
Conavi Medical Announces Grant of Stock Options
-
Syntiant to Showcase Sensor and Edge AI Innovations at CES 2025
-
Hausfeld announces nine senior promotions globally
-
Clear Blue Technologies Announces Closing of Shares for Debt Settlement and Private Placement
-
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
arc, a Leading AI Agent Project, Will Be Listed on CoinW Exchange
-
VYNE Therapeutics Completes Enrollment in Phase 2b Trial Evaluating VYN201 for the Treatment of Nonsegmental Vitiligo
-
Serve Robotics Secures $86 Million in New Financing in December, Solidifying Liquidity Position to Transform Last-Mile Delivery
-
Chart Industries to Present at Goldman Sachs Energy, CleanTech & Utilities Conference
-
Repligen Launches the CTech™ SoloVPE® PLUS System
